Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer (Q37496425)
Jump to navigation
Jump to search
scientific article published on 26 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer |
scientific article published on 26 May 2009 |
Statements
1 reference
Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer (English)
1 reference
William J Gradishar
1 reference
Dimitry Krasnojon
1 reference
Sergey Cheporov
1 reference
Anatoly N Makhson
1 reference
Georgiy M Manikhas
1 reference
Alicia Clawson
1 reference
Paul Bhar
1 reference
1 reference
Identifiers
1 reference